Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | BBIO | BHC | ||
| Company | Cymabay Therapeutics | Bridgebio Pharma Inc | Bausch Health Companies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 32.49 | 24.42 | 8.52 | ||
| High | 32.50 | 24.50 | 8.65 | ||
| Low | 32.48 | 23.68 | 8.44 | ||
| Last | 32.48 | 24.33 | 8.62 | ||
| Change | +0.01 | -0.70 | +0.06 | ||
| % Change | +0.03% | -2.80% | +0.70% | ||
| Volume | 8,356,200 | 1,759,600 | 2,796,600 | ||
| 20-Day Average Volume | 3,390,805 | 1,607,715 | 4,022,970 | ||
| Previous Close | 32.47 | 25.03 | 8.56 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 27.00 | 9.24 | ||
| 20-Day Raw Stochastic | 94.12% | 8.62% | 8.39% | ||
| 20-Day Relative Strength | 78.00% | 34.17% | 42.96% | ||
| Weighted Alpha | +247.60 | -10.43 | +1.81 | ||
| Today's Opinion | 100% Buy | 88% Sell | 40% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -2.48% since 04/18/24 | +0.23% since 04/18/24 | ||
| Low | 32.44 on 03/15/24 | 23.68 on 04/25/24 | 8.42 on 04/22/24 | ||
| High | 32.50 on 03/21/24 | 26.26 on 04/23/24 | 8.80 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -17.22% since 03/25/24 | -9.07% since 03/25/24 | ||
| Low | 32.15 on 02/22/24 | 23.68 on 04/25/24 | 8.36 on 04/11/24 | ||
| High | 32.50 on 03/21/24 | 31.23 on 03/27/24 | 11.46 on 04/03/24 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -32.55% since 01/25/24 | +6.68% since 01/25/24 | ||
| Low | 22.11 on 01/26/24 | 23.68 on 04/25/24 | 7.68 on 02/05/24 | ||
| High | 32.50 on 03/21/24 | 41.04 on 02/15/24 | 11.46 on 04/03/24 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -0.41% since 10/25/23 | +24.75% since 10/25/23 | ||
| Low | 12.32 on 10/13/23 | 23.68 on 04/25/24 | 6.53 on 11/13/23 | ||
| High | 32.50 on 03/21/24 | 44.32 on 12/28/23 | 11.46 on 04/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 4,277,993 | 3,149,851 | ||
| Shares Outstanding, K | 114,724 | 175,832 | 365,412 | ||
| Annual Sales | 31,070,000 | 9,300,000 | 8,757,000,000 | ||
| Annual Net Income | -105,370,000 | -643,200,000 | -592,000,000 | ||
| Last Quarter Sales | 60,000 | 1,750,000 | 2,408,000,000 | ||
| Last Quarter Net Income | -41,900,000 | -168,150,000 | -39,000,000 | ||
| 60-Month Beta | 0.32 | 1.03 | 0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | -0.96 on 02/22/24 | 1.15 on 02/22/24 | ||
| Latest Earnings Date | 03/21/24 | 05/02/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | 1.000 on 11/10/10 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 2.44 | ||